(Q43548829)

24 November 2017

title

Acquired haemophilia: experiences with a standardized approach (English)

1 reference

24 November 2017

1 reference

Grünewald M

1

1 reference

24 November 2017

Beneke H

2

1 reference

24 November 2017

Güthner C

3

1 reference

24 November 2017

Germowitz A

4

1 reference

24 November 2017

Brommer A

5

1 reference

24 November 2017

Griesshammer M

6

1 reference

24 November 2017

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

7

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

164-169

1 reference

Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

Acquired factor VIII inhibitors in nonhemophilic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

DDAVP in acquired hemophilia A: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

Laboratory identification of the lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00488.X

10.1046/J.1365-2516.2001.00488.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference